EIF4E and breast carcinoma: For example, 4EGI-1, an inhibitor of the interaction between translation initiation factors EIF4E1 and EIF4G1 effectively inhibits breast cancer stem cells (CSCs) through selectively reducing translation persistent in breast CSCs [38, 39].